Tumor-specific killer cells in paraneoplastic cerebellar degeneration

Nature Medicine

Volumn 4, Issue 11, 1998, Pages 1321-1324

  Albert, Matthew L ^a   Darnell, Jennifer C ^a   Bender, Armin ^a   Francisco, Loise M ^a   Bhardwaj, Nina ^a   Darnell, Robert B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIBODY RESPONSE; APOPTOSIS; ARTICLE; BREAST CANCER; CASE REPORT; CELLULAR IMMUNITY; CEREBELLUM DEGENERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; OVARY CANCER; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELLS, CULTURED; CEREBELLAR DISEASES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS; LYMPHOID TISSUE; MICE; NERVE DEGENERATION; OVARIAN NEOPLASMS; PARANEOPLASTIC SYNDROMES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; ULTRAVIOLET RAYS;

EID: 0031786356     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/3315     Document Type: Article

References (25)

1. Schuler, G. & Steinman, R.M. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186, 1183-1187 (1997).
2. Boon, T. & Old, L.J. Cancer tumor antigens. Curr. Opin. Immunol. 9, 681-683 (1997).
3. Darnell, R.B. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity and the brain. Proc. Natl. Acad. Sci. USA 93, 4529-4536 (1996).
4. Furneaux, H.L., Reich, L. & Posner, J.P. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40, 1085-1091 (1990).
5. Dropcho, E., Chen, Y., Posner, J. & Old, L. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc. Natl. Acad. Sci. USA 84, 1-5 (1987).
6. Fathallah-Shaykh, H., Wolf, S., Wong, E., Posner, J. & Furneaux, H. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc. Natl. Acad. Sci. USA 88, 3451-3454 (1991).
7. Sakai, K., Mitchell, D.J., Tsukamoto, T. & Steinman, L. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal antibody from a patient with paraneoplastic cerebellar degeneration. Ann. Neurol. 28, 692-698 (1990).
8. Corradi, J.P., Yang, C.W., Darnell, J.C., Dalmau, J. & Darnell, R.B. A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues. J. Neurosci. 17, 1406-1415 (1997).
9. Peterson, K., Rosenblum, M.K., Kotanides, H. & Posner, J.B. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42, 1931-1937 (1992).
10. Bender, A., Sapp, M., Schuler, G., Steinman, R.M. & Bhardwaj, N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196, 121-135 (1996).
11. Albert, M.L., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86-89 (1998).
12. Bennett, S.R. et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478-80 (1998).
13. Boon, T., Cerottini, J.C., Van den Eynde, B., van der Bruggen, P. & Van Pel, A. Tumor antigens recognized by T lymphocytes. Ann. Rev. Immunol. 12, 337-365 (1994).
14. Carmichael, A., Jin, X., Sissons, P. & Borysiewicz, L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177, 249-56 (1993).
15. Koup, R.A. et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J. Exp. Med. 174, 1593-1600 (1991).
16. McMichael, A. Cytotoxic T lymphocytes specific for influenza virus. Curr. Top. Microbiol. Immunol. 189, 75-91 (1994).
17. Darnell, R.B. & DeAngelis, L.M. Regression of small-cell lung carcinoma in patients with paraneoptastic neuronal antibodies. Lancet 341, 21-22 (1993).
18. Devita, V.T., Hellman, S. & Rosenberg, S. in Cancer, Principles and Practice of Oncology, 1930-1931 (J.B. Lippincott, Philadelphia, 1989).
19. Huang, A.Y. et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264, 961-5 (1994).
20. Zitvogel, L. et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183, 87-97 (1996).
21. Dalmau, J. et al. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75, 99-109 (1995).
22. Strand, S. et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nature Med. 2, 1361-1366 (1996).
23. Corriveau, R.A., Huh, G.S. & Shatz, C.J. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 21, 1-20 (1998).
24. Bhardwaj, N. et al. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin. Invest. 94, 797-807 (1994).
25. Barouch, D. et al. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 182, 1847-56 (1995).